Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients

被引:0
作者
Anna Lucia Tornesello
Chiara Botti
Alberto Micillo
Francesco Labonia
Sergio Arpino
Maria Antonietta Isgrò
Serena Meola
Luigi Russo
Ernesta Cavalcanti
Silvia Sale
Carmine Nicastro
Luigi Atripaldi
Noemy Starita
Andrea Cerasuolo
Ulf Reimer
Pavlo Holenya
Luigi Buonaguro
Franco M. Buonaguro
Maria Lina Tornesello
机构
[1] Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”,Molecular Biology and Viral Oncology Unit
[2] Laboratory of Clinical Pathology,Laboratory Medicine Unit
[3] Santobono-Pausilipon Children’s Hospital,Innovative Immunological Models
[4] Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”,undefined
[5] UOC Biochimica Chimica,undefined
[6] AORN Ospedali dei Colli P.O. Monaldi,undefined
[7] JPT Peptide Technologies GmbH,undefined
[8] Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”,undefined
来源
Journal of Translational Medicine | / 21卷
关键词
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2); COVID-19; Peptide microarray; Neutralizing antibodies; Peptide biomarkers; Children SARS-CoV-2 infection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 494 条
[1]  
V'Kovski P(2021)Coronavirus biology and replication: implications for SARS-CoV-2 Nat Rev Microbiol 19 155-170
[2]  
Kratzel A(2020)Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update Cureus 12 2259-2268
[3]  
Steiner S(2021)Understanding the molecular biology of SARS-CoV-2 and the COVID-19 pandemic: a review Infect Drug Resist 14 748-755
[4]  
Stalder H(2020)Covid-19: time for a paradigm change Rev Med Virol 30 529-557
[5]  
Thiel V(2020)Impact of COVID-19 pandemic on socioeconomic and mental health aspects in Nepal Int J Soc Psychiatry 66 685-700
[6]  
Pal M(2019)Human coronavirus: host-pathogen interaction Annu Rev Microbiol 73 3021-3033
[7]  
Berhanu G(2021)Structural biology of SARS-CoV-2 and implications for therapeutic development Nat Rev Microbiol 19 459-468
[8]  
Desalegn C(2022)Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19 Acta Pharmacol Sin 43 708264-183
[9]  
Kandi V(2020)A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Nature 583 175-20
[10]  
Alsobaie S(2021)SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns Front Immunol 12 3-220